| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |